Now Available! | Check out UMR’s 2024 Annual Economic Report and State Toolkits today
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Trials begin for potential COVID-19 drug remdesivir

A drug originally developed to treat Ebola is getting a second chance in the spotlight, as research teams in the United States, Asia and Europe race to test it against the new coronavirus. This week, Northwestern University was among the latest U.S. medical centers to join a large-scale research effort sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID). It is putting remdesivir to the “gold standard” test in medicine: a controlled clinical trial.